CD74-NRG1 fusion
|
LUAD
|
CD74-NRG1 fusion
|
LUAD
|
afatinib Sensitive: C3 – Early Trials
|
afatinib Sensitive: C3 – Early Trials
|
CD74-NRG1 fusion
|
NSCLC
|
CD74-NRG1 fusion
|
NSCLC
|
afatinib Sensitive: C4 – Case Studies
|
afatinib Sensitive: C4 – Case Studies
|
CD74-NRG1 fusion
|
NSCLC
|
CD74-NRG1 fusion
|
NSCLC
|
MCLA-128 Sensitive: C4 – Case Studies
|
MCLA-128 Sensitive: C4 – Case Studies
|
CD74-NRG1 fusion
|
Lung Cancer
|
CD74-NRG1 fusion
|
Lung Cancer
|
MM-121 Sensitive: D – Preclinical
|
MM-121 Sensitive: D – Preclinical
|